Education
About Us
Working with TipRanks
Follow Us
CK Life Sciences International (Holdings), Inc. (HK:0775)
:0775
RESEARCH TOOLSreports
Total Valuation
CK Life Sciences International (Holdings), Inc. has a market cap or net worth of HK$8.17B. The enterprise value is HK$9.47B.
Market CapHK$8.17B
Enterprise ValueHK$9.47B
Share Statistics
CK Life Sciences International (Holdings), Inc. has 9,611,072,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,611,072,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
CK Life Sciences International (Holdings), Inc.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee2.62M
Profits Per Employee8.48K
Employee Count2,033
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of CK Life Sciences International (Holdings), Inc. is ―. CK Life Sciences International (Holdings), Inc.’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, CK Life Sciences International (Holdings), Inc. had revenue of 5.32B and earned 17.25M in profits. Earnings per share was 0.00.
Revenue5.32B
Gross Profit1.64B
Operating Income223.85M
Pretax Income68.58M
Net Income17.25M
EBITDA624.75M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was 293.29M and capital expenditures -287.68M, giving a free cash flow of 5.61M billion.
Operating Cash Flow293.29M
Free Cash Flow5.61M
Free Cash Flow per Share<0.01
Dividends & Yields
CK Life Sciences International (Holdings), Inc. pays an annual dividend of HK$0.008, resulting in a dividend yield of ―
Dividend Per ShareHK$0.008
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.69
52-Week Price Change82.61%
50-Day Moving Average0.63
200-Day Moving Average0.47
Relative Strength Index (RSI)58.25
Average Volume (3m)23.84M
Important Dates
CK Life Sciences International (Holdings), Inc. upcoming earnings date is Aug 5, 2025, TBA Not Confirmed.
Last Earnings DateMar 18, 2025
Next Earnings DateAug 5, 2025
Ex-Dividend DateMay 23, 2023
Financial Position
CK Life Sciences International (Holdings), Inc. as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, CK Life Sciences International (Holdings), Inc. has paid 51.33M in taxes.
Income Tax51.33M
Effective Tax Rate―
Enterprise Valuation
CK Life Sciences International (Holdings), Inc. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
CK Life Sciences International (Holdings), Inc. has HK$562.09M in cash and marketable securities with ― in debt, giving a net cash position of HK$5.38B billion.
Cash & Marketable SecuritiesHK$562.09M
Total Debt―
Net CashHK$5.38B
Net Cash Per ShareHK$0.56
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for CK Life Sciences International (Holdings), Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast3.76%
EPS Growth Forecast-833.33%